DiscoverJAMA Author InterviewsTreatment of Complicated Staphylococcus aureus Bacteremia
Treatment of Complicated Staphylococcus aureus Bacteremia

Treatment of Complicated Staphylococcus aureus Bacteremia

Update: 2025-08-13
Share

Description

Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of Medicine discusses key points of the DOTS randomized clinical trial and more with JAMA Deputy Editor Preeti Malani, MD, MSJ.

Related Content:

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Treatment of Complicated Staphylococcus aureus Bacteremia

Treatment of Complicated Staphylococcus aureus Bacteremia